MAP BioPharma

MAP BioPharma is a leading market access and commercialization consultancy that supports pharmaceutical, biotech, and medtech companies in navigating the complexities of healthcare systems. Headquartered in the United Kingdom, the firm specializes in health economics and outcomes research (HEOR), regulatory affairs, and strategic pricing and reimbursement. A central component of their business is MAP Online, a proprietary digital platform that provides subscribers with up-to-date policy insights and tools for the UK and European markets. The company is highly regarded for its deep expertise in National Health Service (NHS) engagement and submissions to bodies such as NICE and the SMC. In 2021, MAP BioPharma partnered with Kester Capital to accelerate its growth and enhance its digital service offerings.